Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A

Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A

SSZSE:301188
20.75
CNY
-0.17
(-0.81%)
0.12EPS
275.04P/E
8.90BMarket Cap
Apr 29Next Earn

Total Valuation

CNY

As of September 30, 2026, Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A carries a market capitalization of 8.90B, placing it among publicly traded companies globally. Its enterprise value stands at 8.88B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap8.90B
Enterprise Value8.88B

Important Dates

Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A's next confirmed earnings release is scheduled for April 29, 2027.

Earnings Date4/29/2027

Share Statistics

As of September 30, 2026, Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A has 267.54M shares outstanding.

Shares Outstanding267.54M

Valuation Ratios

As of September 30, 2026, Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 275.04. The price-to-sales ratio is 6.54, and the price-to-book ratio stands at 4.53.

PE Ratio275.04
PS Ratio6.54
PB Ratio4.53
P/TBV Ratio4.76

Enterprise Valuation

As of September 30, 2026, Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A trades at an EV/EBITDA multiple of 196.92 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 7.04 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 196.92 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 8.88B versus a market cap of 8.90B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales7.04
EV / EBITDA196.92
EV / EBIT196.92

Financial Position

As of September 30, 2026, Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A maintains a current ratio of 2.01, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 14.60, indicating elevated leverage, while an interest coverage ratio of 2.86 demonstrates limited ability to service its debt obligations.

Current Ratio2.01
Quick Ratio0.49
Debt / Equity14.60
Debt / EBITDA6.37
Interest Coverage2.86

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A posted a return on equity (ROE) of 1.68, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 1.43 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 1.13, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 1.91, useful for judging operating efficiency across full business cycles. The company generates approximately 898,866.37 in revenue per employee across its workforce of 1,403.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.19 indicates how many times Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)1.68
Return on Assets (ROA)1.13
Return on Invested Capital (ROIC)1.43
Return on Capital Employed (ROCE)1.91
Revenue Per Employee898,866.37
Employee Count1,403.00
Inventory Turnover2.19

Taxes

CNY

Over the twelve months ended September 30, 2026, Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A recorded 14.67M in income tax expense. That works out to an effective tax rate of 32.86, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 44.65M, leaving 29.98M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax14.67M
Effective Tax Rate32.86

Stock Price Statistics

CNY

As of the close on November 17, 2026, Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A's stock has gained approximately 18.71% over the past 52 weeks. The 50-day moving average sits at 28.86, while the 200-day moving average is 32.39.

52-Week Price Change18.71%
50-Day Moving Average28.86
200-Day Moving Average32.39

Income Statement

CNY

Over the twelve months ended September 30, 2026, Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A generated 1.26B in revenue and converted that into 29.98M in net income, yielding earnings per share of 0.12. EBITDA reached 45.09M, while operating income came in at 67.58M.

Revenue1.26B
Gross Profit278.41M
Operating Income67.58M
Pretax Income44.65M
Net Income29.98M
EBITDA45.09M
EBIT45.09M
Earnings Per Share (EPS)0.12

Balance Sheet

CNY

As of September 30, 2026, Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A holds 310.72M in cash and equivalents against 287.06M in total debt, resulting in a net debt position of -37.51M. Total book value stands at 1.97B, with working capital of 639.90M providing operational flexibility.

Cash & Cash Equivalents310.72M
Total Debt287.06M
Net Debt-37.51M
Equity (Book Value)1.97B
Book Value Per Share7.35
Working Capital639.90M

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-249.28M

Margins

Over the twelve months ended September 30, 2026, Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A posted a gross margin of 22.08, reflecting its pricing power and cost economics. The operating margin of 5.36 and net profit margin of 2.38 provide insight into operational efficiency.

Gross Margin22.08
Operating Margin5.36
Pretax Margin3.54
Profit Margin2.38
EBITDA Margin3.58

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A paid dividends of 0.13 per share. The dividend payout ratio of 105.54 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -1.27, meaning Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Dividend Per Share0.13
Payout Ratio105.54
Shareholder Yield-1.27

Scores

As of September 30, 2026, Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A has an Altman Z-Score of 7.55, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score7.55